Literature DB >> 7831440

The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

D C Ohuoha1, T M Hyde, J E Kleinman.   

Abstract

Serotonin is a neurotransmitter that is widely distributed throughout the central nervous system. The role of serotonin in schizophrenia is still unclear. Postmortem studies of serotonin receptor subtypes in schizophrenia have been inconclusive for the most part. The most promising findings involve a reduction in 5-HT2 receptors and 5-HT reuptake sites in the prefrontal cortex of schizophrenic patients. In this paper we review the function, distribution and pharmacological characteristics of serotonin receptors. Postmortem studies are also reviewed, focusing upon the role of these receptors in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7831440     DOI: 10.1007/bf02245003

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  148 in total

1.  Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

Authors:  M Toru; S Watanabe; H Shibuya; T Nishikawa; K Noda; H Mitsushio; H Ichikawa; A Kurumaji; M Takashima; N Mataga
Journal:  Acta Psychiatr Scand       Date:  1988-08       Impact factor: 6.392

2.  Indoleamines in blood plasma of schizophrenics a critical study with sensitive and selective methods.

Authors:  S Axelsson; L Nordgren
Journal:  Life Sci       Date:  1974-04-01       Impact factor: 5.037

3.  Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.

Authors:  R C Arora; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Melperone in the treatment of schizophrenia.

Authors:  L Bjerkenstedt
Journal:  Acta Psychiatr Scand Suppl       Date:  1989

5.  Altered platelet serotonin uptake kinetics in schizophrenia and depression.

Authors:  R D Kaplan; J J Mann
Journal:  Life Sci       Date:  1982-08-09       Impact factor: 5.037

6.  Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.

Authors:  H Jackman; D Luchins; H Y Meltzer
Journal:  Biol Psychiatry       Date:  1983-08       Impact factor: 13.382

7.  Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.

Authors:  O Lingjaerde
Journal:  Biol Psychiatry       Date:  1983-12       Impact factor: 13.382

8.  Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations.

Authors:  L Corbett; S T Christian; R D Morin; F Benington; J R Smythies
Journal:  Br J Psychiatry       Date:  1978-02       Impact factor: 9.319

9.  Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.

Authors:  E B De Souza; B L Kuyatt
Journal:  Synapse       Date:  1987       Impact factor: 2.562

10.  Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

View more
  4 in total

1.  Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders.

Authors:  Howard O'Rourke; Julie L Fudge
Journal:  Biol Psychiatry       Date:  2006-01-18       Impact factor: 13.382

2.  Dopamine attenuates evoked inhibitory synaptic currents in central amygdala neurons.

Authors:  Jennifer C Naylor; Qiang Li; Maeng-hee Kang-Park; Wilkie A Wilson; Cynthia Kuhn; Scott D Moore
Journal:  Eur J Neurosci       Date:  2010-10-19       Impact factor: 3.386

3.  The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.

Authors:  Zhimin Li; Mona Boules; Katrina Williams; Joanna Peris; Elliott Richelson
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

4.  Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways.

Authors:  Karina S MacDowell; Eva Munarriz-Cuezva; J Javier Meana; Juan C Leza; Jorge E Ortega
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.